Repligen Corp - RGEN Net Assets per Single Share

Graphic logo of Repligen Corporation (RGEN)

Repligen Corporation (RGEN) production sites are operating at full capacity, expanding sterile workshops to reduce the order backlog. This price chart reflects a market trend characterized by low business sensitivity to economic cycles and macroeconomic shocks. The current indicator is 37.61. Repligen Corporation (RGEN) revenues are based on the supply of chromatography systems and filters to global laboratories and gene therapy developers.

Repligen Corp. (RGEN) Equity per Share: for the period 07/04/2022 - 10/27/2026

repligen.com - analytical breakdowns and key metrics (RGEN)

- price and consensus price forecast:
Stock Price Repligen Corp.|RGEN - Average Forecast Price
- market capitalization data:
Market Value Repligen Corporation|RGEN - Business Value
- book capitalization data:
Book Value per Share Repligen|RGEN - Accounting Capitalization|Market Value to Book Value Ratio repligen.com|RGEN - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Repligen Corporation|RGEN - Long-Term Debt to Capital|Short-Term Debt to Equity Repligen|RGEN - Aggregate Debt Obligations|Debts to Book Capitalization Repligen Corporation
Analysis of all company metrics:Repligen Corp., RGEN
Manufactured products of Repligen

Book value per share determines the net asset value of an enterprise attributable to a single security. This metric allows for an assessment of the company's intrinsic value and determines the capital safety margin. By analyzing the calculated book value per share, an investor identifies risks of undervaluation or excessive leverage. For Repligen Corporation (RGEN), this indicator reflects the tangible basis for the production of high-tech biopharmaceutical equipment. The capitalization of physical assets confirms the company's status as a reliable technological industry leader.

Competitor analysis for Repligen Corporation

TEM (Tempus AI, Inc.) - Book Value per Share|QGEN: Net Asset Value per Share|Net Assets per Single Share Ionis Pharmaceuticals|aviditybiosciences.com (RNA) - Equity per Share|Book Value per Share CRISPR Therapeutics (CRSP)|Equity per Share WGS|Net Assets per Single Share Ultragenyx Pharma RARE|Equity per Share Beam Tx (BEAM)|Book Value per Share SRPT (Sarepta Therapeutics, Inc.)|twistbioscience.com - Book Value per Share|Net Assets per Single Share 10x Genomics (TXG)|NTLA - Accounting Value of a Share|Book Value per Share STOK|BLFS (BioLife) - Net Asset Value per Share|Net Assets per Single Share Wave Life Sciences WVE|Share Book Value MAZE|Net Assets per Single Share Sionna Therapeutics (SION)|Net Assets per Single Share Prime Medicine Inc (PRME)|Book Value per Share TSHA|Net Assets per Share uniQure Pharma QURE|Book Value per Share MGTX|RGNX - Book Value of One Share|Book Value per Share SLDB|OCGN (Ocugen Inc) - Net Asset Value per Share|Net Assets per Single Share Pacific Biosciences of California (PACB)|Equity per Share Benitec Corp (BNTC)|Design Therapeutics (DSGN) - Accounting Value per Share|Accounting Value of a Share rocketpharma.com (RCKT)|4D Molecular Therapeutics, Inc. - Book Value per Share|Lexeo Therapeutics Inc. - Accounting Value per Share|KRRO (Korro Bio, Inc) - Net Assets per Single Share|EDIT: Net Asset Value per Share|Net Assets per Single Share Silence Therapeutics SLN|PRQR (ProQR Therapeutics) - Accounting Value of a Share|Net Assets per Single Share Codexis Inc CDXS|Share Book Value SGMO|Nautilus Biotechnology - Net Assets per Single Share|Net Asset Value per Share MGX (Metagenomi Therapeutics)|Net Assets per Single Share Precision BioSciences, Inc.|Accounting Value of a Share Generation Bio Co GBIO|Boundless Bio - Book Value per Share|Exicure, Inc. (XCUR) - Book Value per Share|IMNN - Accounting Value per Share|Phio Pharmaceuticals Corp. (PHIO) - Book Price of a Share|MBIO: Book Value per Share|Net Assets per Share RNAZ|Bionano Genomics, Inc. - Net Assets per Single Share|Net Asset Value per Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|ImmunoPrecise Antibodies Ltd - Equity per Share|Net Assets per Single Share Omega Therapeutics (OMGA)|OMIC - Accounting Value of a Share|Book Value per Share RGLS (Regulus Therapeutics Inc.)|Syros Pharmaceuticals Inc. (SYRS) - Book Value of One Share|Book Value per Share TBIO (Codex DNA)|Net Asset Value per Share TCON|Net Assets per Single Share Unity Biotechnology UBX